MeiraGTx Banner Image

MeiraGTx has reached its limit for free report views

Work for MeiraGTx? Upgrade Your Profile and unlock all your annual reports.


  • Ticker MGTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
MeiraGTx Logo Image
  • 51-200 Employees
  • Based in New York City, New York
MeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. They currently have five programs in clinical development including three ocular indications, a salivary gland condition, and a Parkinson’s disease program. Their initial focus on diseases of the eye, salivary gland and central nervous systemMore is based on the significant unmet medical need coupled with the high potential gene therapy has to provide meaningful clinical benefit in these areas. With headquarters in New York and London, their global footprint provides them the opportunity to partner with leading institutions around the world, allowing them to deepen their understanding of diseases and their progression.

Most Recent Annual Report

MeiraGTx MOST RECENT 2019 Annual Report and Form 10K

Report Locked. MeiraGTx has reached its limit for free report views.

Older/Archived Annual Reports